Dianeal Low Calcium With Dextrose Injection, Solution
NDC Package 0941-0484-01
Package Information
Dianeal Low Calcium With Dextrose (sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose) injection is dIANEAL peritoneal dialysis solutions are indicated for patients in acute or chronic renal failure. This formulation utilizes a injection, solution delivery system. Marketed by Vantive Us Healthcare Llc, this product is identified by NDC 0941-0484 and is authorized under FDA application NDA017512.
Identification & Billing
- RxCUI: 799999 - calcium chloride 0.00014 MEQ/ML / glucose 1.7 MG/ML / magnesium chloride 0.0000245 MEQ/ML / sodium chloride 0.00368 MEQ/ML / sodium lactate 0.0016 MEQ/ML Intraperitoneal Solution
- RxCUI: 799999 - Calcium Chloride 0.00014 MEQ/ML / Glucose 1.7 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal Solution
- RxCUI: 800003 - calcium chloride 0.00014 MEQ/ML / glucose 1.7 MG/ML / magnesium chloride 0.0000245 MEQ/ML / sodium chloride 0.00368 MEQ/ML / sodium lactate 0.0016 MEQ/ML Intraperitoneal Solution [Dianeal PD-2/4.25]
- RxCUI: 800003 - Calcium Chloride 0.00014 MEQ/ML / Glucose 1.7 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal Solution [Dianeal PD-2/4.25]
- RxCUI: 800003 - Dianeal PD-2/4.25 2500 ML Intraperitoneal Solution
Clinical Specifications
- Acidifying Activity - [MoA] (Mechanism of Action)
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0941 - Vantive Us Healthcare Llc
- 0941-0484 - Dianeal Low Calcium With Dextrose
- 0941-0484-01 - 5000 mL in 1 BAG
- 0941-0484 - Dianeal Low Calcium With Dextrose
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0941-0484-01 identifies a specific commercial package of 5000 ml in 1 bag of Dianeal Low Calcium With Dextrose, a human prescription drug labeled by Vantive Us Healthcare Llc. This injection, solution is formulated for intraperitoneal use and contains calcium chloride; dextrose monohydrate; magnesium chloride; sodium chloride; sodium lactate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vantive Us Healthcare Llc on September 27, 1978. The current certification is valid through December 31, 2027.
How is this Vantive Us Healthcare Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00941048401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.